Big Tech Governance, AI Payoff Risks and Sector Divergence Drive Market Narrative — AstraZeneca Shock, Anthropic Governance Hire, and Mixed Consumer Data Lead Headlines

A late-stage AstraZeneca trial miss and Apollo’s caution about a slower AI payoff punctuate a day of mixed corporate beats and governance moves. Investors are parsing strong consumer prints in apparel and petrol windfalls against legal and pipeline risks, while debates intensify over whether to lean risk‑on in growth allocations.